In recent years, the term “personalized medicine,” which indicates a treatment tailored for each individual patient, has been widely replaced by the term “precision medicine.” This latter, in a more accurate and broader way, associates patient’s care with genetic, environmental, clinical, and lifestyle factors. In the oncological community, precision medicine refers to genomics-driven cancer medicine.1
Orlandi E, Licitra L. Personalized Medicine and the Contradictions and Limits of First-Generation Deescalation Trials in Patients With Human Papillomavirus–Positive Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. 2018;144(2):99–100. doi:10.1001/jamaoto.2017.2308
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: